about
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway.Fidaxomicin and OP-1118 inhibit C. difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-κB activity.Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism
P50
description
investigador
@es
researcher
@en
name
Jiani Wang
@en
type
label
Jiani Wang
@en
prefLabel
Jiani Wang
@en
P31
P496
0000-0002-4043-2946